...
首页> 外文期刊>The American journal of Chinese medicine >Wedelia chinensis inhibits nasopharyngeal carcinoma CNE-1 cell growth by inducing G2/M arrest in a Chk1-dependent pathway
【24h】

Wedelia chinensis inhibits nasopharyngeal carcinoma CNE-1 cell growth by inducing G2/M arrest in a Chk1-dependent pathway

机译:Wedelia chinensis通过诱导Chk1依赖性途径中的G2 / M阻滞抑制鼻咽癌CNE-1细胞的生长

获取原文
获取原文并翻译 | 示例
           

摘要

Although Wedelia chinensis, an herb in traditional Chinese medicine, has been widely used for the treatment of inflammation, the effects of W. chinensis on cancer cell growth and the related molecular mechanisms behind these effects have largely remained unexplored to date. In the present study, W. chinensis plant extracts were obtained using either ethanol (E), petroleum ether (PE), ethyl acetate (EA) or butyl alcohol (BA). Then, extracts were examined for bioactivity in vitro via MTT assay in five human cancer cell lines. Our results showed that one subfraction of the EA extract (EA6) was cytotoxic to nasopharyngeal carcinoma (NPC) CNE-1 cells, among all cell lines evaluated. Treatment of CNE-1 cells with EA6 resulted in significant G2/M cell cycle arrest and modest apoptosis. EA6 induced Chk1 activation and inhibition of Chk1 in CNE-1 cells by RNA interference (RNAi) markedly abrogated EA6-mediated G2/M arrest and abolished EA6-induced cytotoxicity. EA6 treatment resulted in notable reduction of c-myc expression in CNE-1 cells, whereas silencing Chk1 inhibited such effects of EA6. Our results indicate that Chk1 is a novel molecular target of EA6 in NPC cells and also suggest an intervention strategy for NPC by EA6 exploring its molecular mechanisms of action.
机译:尽管中国传统草药中的韦德利亚草(Wedelia chinensis)已被广泛用于治疗炎症,但迄今为止,中华W对癌细胞生长的影响以及这些作用背后的相关分子机制尚未得到充分探索。在本研究中,使用乙醇(E),石油醚(PE),乙酸乙酯(EA)或丁醇(BA)获得了中华白茅的植物提取物。然后,在5种人类癌细胞系中通过MTT分析检测提取物的体外生物活性。我们的结果表明,在所有评估的细胞系中,EA提取物(EA6)的一个亚部分对鼻咽癌(NPC)CNE-1细胞具有细胞毒性。用EA6处理CNE-1细胞导致明显的G2 / M细胞周期停滞和适度的凋亡。 EA6诱导的CNK-1细胞中Chk1的激活和RNA干扰(RNAi)对Chk1的抑制显着废除了EA6介导的G2 / M阻滞,并废除了EA6诱导的细胞毒性。 EA6处理导致CNE-1细胞中c-myc表达明显降低,而沉默Chk1抑制EA6的这种作用。我们的结果表明,Chk1是NPC细胞中EA6的新型分子靶标,并且还提出了EA6探索其作用机制的NPC干预策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号